{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nIn papillary thyroid cancer, MIR6730 appears among a set of dysregulated miRNAs that distinguish tumor from non‐tumor tissue. Specifically, its altered expression contributes to a four‐miRNA prognostic signature that can reliably stratify patients into high‐risk and low‐risk groups based on overall survival outcomes. Although the exact molecular mechanisms of MIR6730 remain to be fully defined, its differential regulation in cancer versus normal tissues suggests it may participate in tumorigenic pathways—potentially acting in an oncogenic or tumor‐suppressive manner—and thus holds promise as a clinically useful biomarker for prognostication in PTC."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xiong Chengfeng, Cai Gengming, Zhang Junjia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA signature predicts survival in papillary thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28966"}], "href": "https://doi.org/10.1002/jcb.28966"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31099134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31099134"}]}]}]}